Medpace Holdings (MEDP) Common Equity (2015 - 2026)

Medpace Holdings has reported Common Equity for 12 years, with the latest figure at $598.3 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 0.79% year-over-year to $598.3 million; the trailing twelve-month figure through Mar 2026 stood at $598.3 million (up 0.79% YoY), and the FY2025 full-year result was $459.1 million, down 44.39% from the prior year.
• Common Equity for Q1 2026 stood at $598.3 million, up from $459.1 million in the prior quarter.
• The five-year high for Common Equity was $881.4 million in Q3 2024, with the low at $172.4 million in Q2 2025.
• Historically, Common Equity has averaged $508.9 million across 5 years, with a median of $470.9 million in 2023.
• Annual changes were most pronounced in 2024 — Common Equity soared 95.26% — and 2025, when it slumped 77.43%.
• Medpace Holdings' Common Equity stood at $386.4 million in 2022, then soared by 44.66% to $558.9 million in 2023, then soared by 47.7% to $825.5 million in 2024, then sank by 44.39% to $459.1 million in 2025, then soared by 30.33% to $598.3 million in 2026.
• The last three Common Equity figures came in at $598.3 million (Q1 2026), $459.1 million (Q4 2025), and $293.6 million (Q3 2025), per Business Quant data.